```html

Palmar Xanthomas (Xanthomas on the Palms)

What is Xanthomas (Palmar)?

Palmar xanthomas are yellow‑orange, flat or slightly raised plaques that appear on the palmar surfaces of the hands (the skin of the palms). They are collections of lipid‑laden macrophages (called foamy histiocytes) that accumulate in the dermis when blood lipid levels become abnormally high. While xanthomas can develop anywhere on the body, palmar involvement is relatively uncommon and often points to an underlying metabolic or genetic disorder rather than a simple, isolated skin finding.

Because the skin of the palms is thick and lacks hair follicles, these lesions tend to be smooth, well‑demarcated, and sometimes give the hand a “cobblestone” appearance. They are typically painless and do not ulcerate, but their presence is a visual clue that systemic lipid abnormalities may be present and warrants further evaluation.

Common Causes

Palmar xanthomas are most often a cutaneous manifestation of a systemic lipid disorder. The most frequent underlying conditions include:

• Familial hypercholesterolemia (FH) – an autosomal‑dominant disorder causing very high LDL‑cholesterol.
• Familial dysbetalipoproteinemia (type III hyperlipoproteinemia) – characterized by elevated remnant particles.
• Familial combined hyperlipidemia – mixed elevation of LDL, VLDL, and triglycerides.
• Primary (genetic) hypertriglyceridemia – very high triglyceride levels that can coexist with xanthomas.
• Secondary hyperlipidemia due to uncontrolled diabetes mellitus – especially type 2 diabetes with poor glycemic control.
• Hypothyroidism – low thyroid hormone reduces LDL receptor activity, raising cholesterol.
• Cholestatic liver disease (e.g., primary biliary cholangitis, primary sclerosing cholangitis) – impaired bile flow leads to cholesterol accumulation.
• Nephrotic syndrome – massive protein loss triggers hepatic overproduction of lipoproteins.
• Medication‑induced lipid changes – drugs such as cyclosporine, retinoids, or certain antiretrovirals.
• Rare metabolic disorders – such as sitosterolemia or cerebrotendinous xanthomatosis.

Associated Symptoms

Palmar xanthomas rarely occur in isolation. Patients often report or exhibit other signs related to the underlying lipid or systemic disorder:

• Other skin xanthomas (tendon, tuberous, eruptive, or planar) on elbows, knees, Achilles tendon, or eyelids.
• Arcus corneae – a gray‑white ring around the cornea, common in severe hypercholesterolemia.
• Chest or abdominal pain from premature atherosclerotic coronary artery disease.
• Fatigue, polyuria, and polydipsia if diabetes is present.
• Weight gain, central obesity, or metabolic syndrome features.
• Hepatomegaly or jaundice in cholestatic liver disease.
• Proteinuria or swelling (edema) with nephrotic syndrome.
• Hair loss, cold intolerance, or constipation with hypothyroidism.

When to See a Doctor

Because palmar xanthomas can signal serious metabolic disease, prompt medical evaluation is recommended if you notice any of the following:

• New‑onset yellow‑orange plaques on the palms, especially if they are spreading.
• Family history of early heart attack, stroke, or known lipid disorders.
• Associated skin lesions elsewhere on the body.
• Unexplained chest discomfort, shortness of breath, or leg pain on exertion.
• Symptoms of diabetes (excessive thirst, frequent urination, blurred vision).
• Signs of liver disease (jaundice, dark urine, itching).
• Unexplained swelling around the eyes or ankles.

If any of these are present, schedule a primary‑care or dermatology appointment within weeks rather than months.

Diagnosis

Diagnosing palmar xanthomas involves a combination of visual assessment, laboratory testing, and sometimes imaging.

Clinical Examination

• Dermatologic inspection: description of size, color, distribution, and texture.
• Palpation to confirm the lesions are non‑tender and non‑fluctuant.
• Search for other xanthoma types and signs of systemic disease.

Laboratory Evaluation

• Lipid profile – fasting total cholesterol, LDL‑C, HDL‑C, triglycerides, and ApoB.
• Blood glucose & HbA1c – to assess for diabetes.
• Thyroid‑stimulating hormone (TSH) and free T4 – rule out hypothyroidism.
• Liver function tests (ALT, AST, ALP, bilirubin) – screen for cholestasis.
• Urine protein‑to‑creatinine ratio – evaluate for nephrotic syndrome.
• Genetic testing (e.g., LDLR, APOE, PCSK9) when familial hypercholesterolemia is suspected.

Imaging & Specialized Tests

• Carotid duplex ultrasound or coronary CT angiography if cardiovascular risk is high.
• Skin biopsy (rarely needed) – histology shows foamy macrophages within the dermis.
• Magnetic resonance cholangiopancreatography (MRCP) when cholestatic liver disease is a concern.

Treatment Options

Therapy centers on two goals: removing or reducing the skin lesions and, more importantly, correcting the underlying lipid abnormality.

Medical Management

• Statins (e.g., atorvastatin, rosuvastatin) – first‑line agents that lower LDL‑C and often cause regression of xanthomas within months.
• Ezetimibe – blocks intestinal cholesterol absorption; useful in combination with statins.
• PCSK9 inhibitors (alirocumab, evolocumab) – very potent LDL‑C reducers for familial hypercholesterolemia or statin‑intolerant patients.
• Fibrates (gemfibrozil, fenofibrate) – primarily lower triglycerides; may help eruptive or tuberous xanthomas.
• Niacin – can raise HDL‑C and lower triglycerides, but side‑effects limit its use.
• Omega‑3 fatty acids – prescription‑grade EPA/DHA for severe hypertriglyceridemia.
• Thyroid hormone replacement – levothyroxine for hypothyroidism.
• Glycemic control – metformin, GLP‑1 receptor agonists, or insulin when diabetes is present.
• Liver‑directed therapy – ursodeoxycholic acid for primary biliary cholangitis.
• Immunosuppressant dose adjustment – if medication‑induced hyperlipidemia is identified.

Procedural / Dermatologic Options

• Laser therapy (e.g., CO₂ laser) – can shave off stubborn plaques, but lesions often recur if lipids remain uncontrolled.
• Cryotherapy – occasional use for small, isolated lesions.
• Surgical excision – reserved for very thick, symptomatic plaques that interfere with hand function.

Home & Lifestyle Measures

• Adopt a heart‑healthy diet: low in saturated fats and trans fats, rich in soluble fiber, legumes, nuts, and oily fish (≥2 servings/week).
• Limit dietary cholesterol to <300 mg/day; <200 mg/day if LDL‑C is very high.
• Maintain a healthy weight (BMI 18.5–24.9 kg/m²) through regular physical activity (≥150 min of moderate aerobic exercise/week).
• Avoid tobacco and limit alcohol (<2 drinks/day for men, <1 for women).
• Stay hydrated and monitor blood glucose if diabetic.
• Attend regular follow‑up labs to track lipid levels and adjust medications promptly.

Prevention Tips

While you cannot prevent genetic lipid disorders, you can minimize the risk of palmar xanthomas and their complications by:

• Screening close relatives for lipid abnormalities if a familial condition is diagnosed.
• Undergoing lipid testing at least once every 4–6 years for adults, earlier if risk factors exist.
• Following prescribed lipid‑lowering therapy exactly as directed.
• Adhering to a Mediterranean‑style diet and regular exercise regimen from a young age.
• Managing comorbidities (diabetes, hypothyroidism, liver disease) aggressively.
• Discussing medication side‑effects with your prescriber; request alternatives if you develop hyperlipidemia on a drug.
• Keeping a skin diary – note any new or changing lesions and bring photos to appointments.

Emergency Warning Signs

Bottom Line

Palmar xanthomas are a visual alarm bell for underlying lipid disorders that can dramatically increase cardiovascular risk. Early recognition, comprehensive laboratory work‑up, and aggressive lipid‑lowering therapy are essential to reverse the skin lesions and, most importantly, prevent heart attacks, strokes, and other serious complications. If you notice yellow‑orange plaques on your palms, schedule a medical evaluation promptly—don’t wait for other symptoms to appear.

References

• Mayo Clinic. “Xanthomas.” Accessed June 2024. https://www.mayoclinic.org/diseases-conditions/xanthomas/symptoms-causes/syc-20356092
• National Heart, Lung, and Blood Institute (NHLBI). “Familial Hypercholesterolemia.” Updated 2023. https://www.nhlbi.nih.gov/health/familial-hypercholesterolemia
• American Diabetes Association. “Standards of Care in Diabetes—2024.” https://diabetes.org/clinical-guidelines
• Cleveland Clinic. “Hypertriglyceridemia.” 2024. https://my.clevelandclinic.org/health/diseases/17230-hypertriglyceridemia
• World Health Organization. “WHO Guideline on Lipid Modification for Cardiovascular Disease Prevention.” 2023. https://www.who.int/publications/i/item/9789240031595
• Higgins, J. et al. “Skin Manifestations of Dyslipidemia.” *Journal of the American Academy of Dermatology*, 2022; 86(4): 800‑812.

```